Back

Modeling cardioinflammatory TET2 CHIP in engineered cardiac ventricular tissue reveals therapeutics for disease resolution

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Genetic and epigenetic regulation of cardiovascular disease: mechanisms and therapeutic opportunities Gene Therapy, Cell Therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yue Wang

Institute of Cardiovascular Regeneration, Frankfurt (Germany)

6 More presentations in this session

Presentation thumbnail
N6-methyladenosine regulator Rbm15b protects against adverse cardiac remodeling under pressure overload through modulating RNA methylation
Doctor Y. Higashikuni (Tochigi, JP)
Abstract Slides Video
Presentation thumbnail
Epigenetic editing of chromatin readers rescues doxorubicin-induced endothelial senescence and vascular dysfunction
Doctor S. Mohammed (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Longer leucocyte telomere length protects from adverse cardiovascular effects of prolonged air pollution exposure
Doctor M. Sagris (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Unraveling the molecular mechanisms underlying the coronary artery disease risk gene REST
Doctor T. Dang (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Identification of genetic loci associated with aortic stiffness using deep learning and genome-wide association analysis on 45,789 UK Biobank participants
Doctor N. Paliwal (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Genetic and epigenetic regulation of cardiovascular disease: mechanisms and therapeutic opportunities

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Young Investigator Award Session in Basic and Translational Sciences
thumbnail
Congress Session
Basic and Translational Late-Breaking Science session
thumbnail
Congress Session
Clonal haematopoiesis of indeterminate potential: a novel cardiovascular risk factor

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources